Euphrates Vascular
MO - St. LouisBiotechnology
Focus: Euphrates Vascular is a public-stage biotechnology company focused on percutaneous reperfusion systems for acute cardiovascular and stroke applications, headquartered in St. Louis, Missouri. The company operates in a highly specialized medical device-biotech hybrid space targeting ischemic stroke and related vascular emergencies.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Euphrates Vascular
AI assessmentNot HiringNo open roles listed right now. Follow Euphrates Vascular to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Pulse NanoMED System
Acute Ischemic Stroke AISClinical Trials (1)
NCT06052969Pulse Endovascular ReperFUSION for Acute Ischemic Stroke
N/AHelp build intelligence for Euphrates Vascular
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.